E. Ehrnrooth
Impact in
- Otorhinolaryngology top 1%
- Head and Neck Cancer Studies
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research
Papers in
- Oncology 31
- Cancer Immunotherapy and Biomarkers 9
- HER2/EGFR in Cancer Research 9
- Lung Cancer Research Studies 8
- Colorectal Cancer Treatments and Studies 5
- Peptidase Inhibition and Analysis 4
-
- Lung Cancer Treatments and Mutations 27
- Co-authors
- Hans von der Maase (4 shared papers)Philip Rossen (1 shared paper)Robert Zachariae (1 shared paper)Anders Bonde Jensen (1 shared paper)Charlotte Gjørup Pedersen (1 shared paper)Ezra E.W. Cohen (14 shared papers)Mai-Britt Zocca (4 shared papers)Didier Cupissol (6 shared papers)
- Journals
- Journal of Clinical Oncology (12 papers)Annals of Oncology (11 papers)Journal of Thoracic Oncology (4 papers)European Journal of Cancer (3 papers)Cancer Research (2 papers)
- Partner nations
- United StatesSpainDenmark
In The Last Decade
E. Ehrnrooth
56 papers receiving 1.8k citations
E. Ehrnrooth's Hit Papers
Peers
Comparison fields: 5 of 104
- Otorhinolaryngology 314
- Oncology 706
- Immunology 355
- Pulmonary and Respiratory Medicine 384
- Psychiatry and Mental health 158
Countries citing papers authored by E. Ehrnrooth
This map shows the geographic impact of E. Ehrnrooth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Ehrnrooth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Ehrnrooth more than expected).
Fields of papers citing papers by E. Ehrnrooth
This network shows the impact of papers produced by E. Ehrnrooth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Ehrnrooth. The network helps show where E. Ehrnrooth may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Ehrnrooth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 470 | |
| 2 | Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial Hit paper breakdown → | 2015 | 302 |
| 3 | 2020 | 155 | |
| 4 | 2014 | 148 | |
| 5 | 2021 | 147 | |
| 6 | 1998 | 88 | |
| 7 | 2012 | 72 | |
| 8 | 1991 | 38 | |
| 9 | 2022 | 38 | |
| 10 | 2016 | 33 | |
| 11 | 2013 | 32 | |
| 12 | 2023 | 27 | |
| 13 | 2019 | 25 | |
| 14 | 2017 | 25 | |
| 15 | 2009 | 22 | |
| 16 | 2017 | 22 | |
| 17 | 2013 | 16 | |
| 18 | 1992 | 16 | |
| 19 | The effects of low-dose methotrexate on thymidylate synthetase activity in human peripheral blood mononuclear cells. | 2001 | 14 |
| 20 | 2010 | 12 |
About E. Ehrnrooth
E. Ehrnrooth is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Otorhinolaryngology and Immunology, having authored 57 papers that have together received 1.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (27 papers), Cancer Immunotherapy and Biomarkers (9 papers), HER2/EGFR in Cancer Research (9 papers), Lung Cancer Research Studies (8 papers), Head and Neck Cancer Studies (7 papers), Immunotherapy and Immune Responses (6 papers), Colorectal Cancer Treatments and Studies (5 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Otorhinolaryngology (314 citations), Oncology (706 citations), Immunology (355 citations), Pulmonary and Respiratory Medicine (384 citations) and Psychiatry and Mental health (158 citations). E. Ehrnrooth has collaborated with scholars based in United States, Spain and Denmark. Frequent co-authors include Hans von der Maase, Philip Rossen, Robert Zachariae, Anders Bonde Jensen, Charlotte Gjørup Pedersen, Ezra E.W. Cohen, Mai-Britt Zocca, Didier Cupissol, Jérôme Fayette and Paul M. Clément. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal of Thoracic Oncology, European Journal of Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.